(IGIB) 5-10 Year Investment Grade - Overview
Etf: Bonds, Investment-Grade, Corporate, 5-10Y, USD
Dividends
| Dividend Yield | 5.05% |
| Yield on Cost 5y | 4.87% |
| Yield CAGR 5y | 15.68% |
| Payout Consistency | 92.9% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 2.94% |
| Relative Tail Risk | 0.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.98 |
| Alpha | 3.88 |
| Character TTM | |
|---|---|
| Beta | 0.064 |
| Beta Downside | 0.029 |
| Drawdowns 3y | |
|---|---|
| Max DD | 6.61% |
| CAGR/Max DD | 1.03 |
Description: IGIB 5-10 Year Investment Grade January 02, 2026
The iShares 5-10 Year Investment Grade Corporate Bond ETF (IGIB) seeks to track its benchmark by holding at least 80 % of its assets in the index’s component securities and at least 90 % in fixed-income securities that match the index’s composition. Up to 10 % of the portfolio may be allocated to futures, options, swaps, or other fixed-income instruments that BFA believes will improve tracking fidelity.
Key metrics (as of the latest filing) include an expense ratio of 0.07 %, a weighted-average maturity of roughly 7 years, and a current distribution yield near 3.8 %. The fund’s credit exposure is concentrated in investment-grade issuers, with an average credit rating of A-, and its assets under management exceed $6 billion, providing ample liquidity.
Performance of IGIB is closely tied to macro-economic drivers such as the Federal Reserve’s policy rate trajectory, corporate credit spread dynamics, and inflation expectations. A flattening yield curve or a shift toward higher rates can compress the fund’s price appreciation, while a stable or easing credit environment tends to support its total return.
For a deeper quantitative dive, you might explore ValueRay’s analytics on IGIB’s risk-adjusted performance.
What is the price of IGIB shares?
Over the past week, the price has changed by +0.31%, over one month by +0.35%, over three months by +1.31% and over the past year by +8.89%.
Is IGIB a buy, sell or hold?
What are the forecasts/targets for the IGIB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 58.6 | 8.6% |
IGIB Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 17.66b USD (17.66b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 17.66b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 17.66b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.15% (E(17.66b)/V(17.66b) * Re(6.15%) + (debt-free company))
Discount Rate = 6.15% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)